Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 324.88% is 165% above its 1-year average of 122.61%, around the middle of its 1-year range (0.00%–566.66%).
164.97% above its 12-month average of 122.61%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 46.38%.
NET PROFIT MARGIN
324.88%
NET PROFIT MARGIN AVG TTM
122.61%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-47.12%
NET PROFIT MARGIN AVG 15Y
-211.33%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+164.97%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+789.49%
CURRENT VS 15Y AVG
+253.73%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 819 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Omeros Corporation
Market Cap
$1.34B
Net Profit Margin
324.88%
TTM Avg
122.61%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.32B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.32B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.38B
Net Profit Margin
-2728.04%
TTM Avg
-1093.44%
3Y Avg
-2386.05%
5Y Avg
-1590.70%
Market Cap
$1.39B
Net Profit Margin
-10773.46%
TTM Avg
416506.27%
3Y Avg
203244.58%
5Y Avg
135206.06%
Market Cap
$1.40B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.41B
Net Profit Margin
2.93%
TTM Avg
3.18%
3Y Avg
2.55%
5Y Avg
2.48%
Market Cap
$1.41B
Net Profit Margin
82.37%
TTM Avg
-82.37%
3Y Avg
-592.43%
5Y Avg
-414.63%
Market Cap
$1.42B
Net Profit Margin
-81.79%
TTM Avg
-93.52%
3Y Avg
-130.36%
5Y Avg
-119.92%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omeros Corporation (OMER) | $1.34B | 324.88% | 122.61% | 0.00% | 0.00% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | 0.00% | 0.00% | 0.00% | 0.00% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.32B | 0.00% | 0.00% | 0.00% | 0.00% |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.38B | -2728.04% | -1093.44% | -2386.05% | -1590.70% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -10773.46% | 416506.27% | 203244.58% | 135206.06% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 0.00% | 0.00% | 0.00% | 0.00% |
| The Pennant Group, Inc. (PNTG)vs › | $1.41B | 2.93% | 3.18% | 2.55% | 2.48% |
| AnaptysBio, Inc. (ANAB)vs › | $1.41B | 82.37% | -82.37% | -592.43% | -414.63% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.42B | -81.79% | -93.52% | -130.36% | -119.92% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
Operating Margin
0.0%
Net Profit Margin
324.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 46.38% |
| 2026-03-31 | 566.66% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | -351.26% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -350.57% |
| 2020-09-30 | -147.29% |
| 2020-06-30 | -246.08% |
| 2020-03-31 | -123.34% |
| 2019-12-31 | -87.46% |
| 2019-09-30 | -55.14% |
| 2019-06-30 | -54.02% |
| 2019-03-31 | -111.78% |
| 2018-12-31 | -106.89% |
| 2018-09-30 | -856.60% |
| 2018-06-30 | -2036.01% |
| 2018-03-31 | -1892.57% |
| 2017-12-31 | -120.28% |
| 2017-09-30 | -34.55% |
| 2017-06-30 | -83.72% |
| 2017-03-31 | -123.11% |
| 2016-12-31 | -152.13% |
| 2016-09-30 | -123.68% |
| 2016-06-30 | -126.07% |
| 2016-03-31 | -276.84% |
| 2015-12-31 | -297.02% |
| 2015-09-30 | -611.26% |
| 2015-06-30 | -523.38% |
| 2015-03-31 | -4811.60% |
| 2014-12-31 | -11507.22% |
| 2014-09-30 | -8564.02% |
| 2014-06-30 | -39980.00% |
| 2014-03-31 | -16642.00% |
| 2013-12-31 | -1091.72% |
| 2013-09-30 | -7076.53% |
| 2013-06-30 | -9708.57% |
| 2013-03-31 | -957.90% |
| 2012-12-31 | -488.57% |
| 2012-09-30 | -936.91% |
| 2012-06-30 | -559.57% |
| 2012-03-31 | -594.59% |
| 2011-12-31 | -892.48% |
| 2011-09-30 | -659.78% |
| 2011-06-30 | -458.10% |
| 2011-03-31 | -528.01% |
| 2010-12-31 | -740.88% |
| 2010-09-30 | -2974.41% |
| 2010-06-30 | -1570.22% |
| 2010-03-31 | -1762.17% |
| 2009-12-31 | -1286.18% |
| 2009-09-30 | -885.97% |
| 2009-06-30 | -1646.63% |
| 2009-03-31 | -2782.74% |
| 2008-12-31 | -3526.52% |
| 2008-09-30 | -1473.05% |
